{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:06:13Z","timestamp":1760043973679,"version":"3.37.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.leukres.2012.05.006","type":"journal-article","created":{"date-parts":[[2012,6,7]],"date-time":"2012-06-07T17:45:36Z","timestamp":1339091136000},"page":"1229-1236","source":"Crossref","is-referenced-by-count":15,"title":["Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: A multicenter validation study"],"prefix":"10.1016","volume":"36","author":[{"given":"Kiyoyuki","family":"Ogata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Kakumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunori","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineo","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohiko","family":"Shibayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiko","family":"Emi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiko","family":"Motoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihide","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinuko","family":"Mitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Naoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruo","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumimaro","family":"Takaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2012.05.006_bib0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1053\/j.seminoncol.2011.04.007","article-title":"Classification and prognostic evaluation of myelodysplastic syndromes","volume":"38","author":"Cazzola","year":"2011","journal-title":"Semin Oncol"},{"key":"10.1016\/j.leukres.2012.05.006_bib0010","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1182\/blood.V98.4.979","article-title":"Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome","volume":"98","author":"Stetler-Stevenson","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.05.006_bib0015","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1182\/blood-2002-01-0222","article-title":"Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome","volume":"100","author":"Ogata","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.05.006_bib0020","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.5858\/2003-127-1140-UCFCTI","article-title":"Using 4-color flow cytometry to identify abnormal myeloid populations","volume":"127","author":"Kussick","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.leukres.2012.05.006_bib0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2002-09-2768","article-title":"Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation","volume":"102","author":"Wells","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.05.006_bib0030","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.leu.2403680","article-title":"Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome","volume":"19","author":"Malcovati","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2012.05.006_bib0035","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.leu.2404142","article-title":"Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome","volume":"20","author":"Della Porta","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2012.05.006_bib0040","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood-2005-12-4916","article-title":"Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes","volume":"108","author":"Ogata","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.05.006_bib0045","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2007-07-098764","article-title":"Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry","volume":"111","author":"van de Loosdrecht","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.05.006_bib0050","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1002\/cncr.25353","article-title":"Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data","volume":"116","author":"Kern","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2012.05.006_bib0055","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.leukres.2006.11.009","article-title":"Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference","volume":"31","author":"Valent","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2012.05.006_bib0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.leukres.2007.04.020","article-title":"Flow cytometry in myelodysplastic syndromes: report from a working conference","volume":"32","author":"Loken","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2012.05.006_bib0065","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3324\/haematol.2009.005801","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNET working conference on flow cytometry in myelodysplastic syndromes","volume":"94","author":"van de Loosdrecht","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2012.05.006_bib0070","doi-asserted-by":"crossref","unstructured":"Westers TM, Ireland R, Kern W, Alhan C, Balleisen JS, Bettelheim P, et al. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European Leukemia Net working group. Leukemia; http:\/\/dx.doi.org\/10.1038\/leu.2012.30.","DOI":"10.1038\/leu.2012.30"},{"key":"10.1016\/j.leukres.2012.05.006_bib0075","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2009-12-255125","article-title":"Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes","volume":"116","author":"Kondo","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.05.006_bib0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.leukres.2008.07.006","article-title":"Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes","volume":"33","author":"Satoh","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2012.05.006_bib0085","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.05.006_bib0090","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.05.006_bib0095","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","article-title":"Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes","volume":"25","author":"Malcovati","year":"2007","journal-title":"J. Clin Oncol"},{"key":"10.1016\/j.leukres.2012.05.006_bib0100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.leukres.2007.08.022","article-title":"Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes","volume":"32","author":"Satoh","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2012.05.006_bib0105","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3324\/haematol.2009.008532","article-title":"Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study","volume":"94","author":"Ogata","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2012.05.006_bib0185","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2011.048421","article-title":"Multicentre validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study","volume":"97","author":"Della Porta","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2012.05.006_bib0115","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/CCM.0b013e318218a05b","article-title":"International validation of the out-of-hospital cardiac arrest score in the United States","volume":"39","author":"Hunziker","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.leukres.2012.05.006_bib0120","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1182\/blood-2008-04-149070","article-title":"The largest prospective warfarin-treated cohort supports genetic forecasting","volume":"113","author":"Wadelius","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.05.006_bib0125","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1182\/blood-2005-04-1543","article-title":"Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome","volume":"106","author":"Sternberg","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.05.006_bib0130","series-title":"Immunophenotyping","first-page":"133","article-title":"Normal antigen expression in hematopoiesis: basis for interpreting leukemia phenotypes","author":"Loken","year":"2000"},{"key":"10.1016\/j.leukres.2012.05.006_bib0135","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.4049\/jimmunol.149.6.2110","article-title":"Expression of CD7 on normal human myeloid progenitors","volume":"149","author":"Chabannon","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.leukres.2012.05.006_bib0140","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1084\/jem.177.6.1531","article-title":"T lymphocyte differentiation in vitro from adult human prethymic CD34+ bone marrow cells","volume":"177","author":"Tjonnfjord","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2012.05.006_bib0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/10428199809057588","article-title":"CD7 positive hematopoietic progenitors and acute myeloid leukemia and other minimally differentiated leukemia","volume":"31","author":"Tien","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2012.05.006_bib0150","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2141.1989.tb00284.x","article-title":"CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturity","volume":"73","author":"Lo Coco","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2012.05.006_bib0155","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1046\/j.1365-2141.2001.03139.x","article-title":"Reappraisal of the clinical significance of CD7 expression in association with cytogenetics in de novo acute myeloid leukaemia","volume":"115","author":"Ogata","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2012.05.006_bib0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/blood-2005-05-2155","article-title":"Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML","volume":"107","author":"Yong","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.05.006_bib0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1158\/1078-0432.505.11.2","article-title":"CD34+CD7+ leukemic progenitor cells may be involved in maintenance and clonal evolution of chronic myeloid leukemia","volume":"11","author":"Kosugi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2012.05.006_bib0170","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood.V97.6.1809","article-title":"B7-H1 co stimulation preferentially enhances CD28-independent T-helper cell function","volume":"97","author":"Tamura","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2012.05.006_bib0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF02983556","article-title":"Immunology of B7-H1 and its roles in human diseases","volume":"78","author":"Tamura","year":"2003","journal-title":"Int J Hematol."},{"key":"10.1016\/j.leukres.2012.05.006_bib0180","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.leukres.2011.06.022","article-title":"Disease progression mechanism in myelodysplastic syndromes: insight into the role of the microenvironment","volume":"35","author":"Ishibashi","year":"2011","journal-title":"Leuk Res"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612002317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212612002317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T06:25:37Z","timestamp":1687501537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212612002317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0145212612002317"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2012.05.006","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}